Evidence map›Paper›PMID 41735429›Full record

ArticleScientific reports2026

Clustering reveals diagnostic overlap between Still's disease and a hyperinflammatory subset of seronegative rheumatoid arthritis.

Alexandre Mercier-Guery, Thomas El-Jammal, Nour El-Nayef, Emmanuel Massy, Nicolas Fournier, Pascal Sève, Cyrille Confavreux, Yvan Jamilloux, Fabienne Coury

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexandre Mercier-Guery *University of Lyon, University Lyon 1, Lyon, 69100, France. alexandre.mercier@chu-lyon.fr.
Thomas El-Jammal *Internal medicine, National Reference Center for AutoInflammatory Diseases (CEREMAIA), University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, 69004, France.
Nour El-NayefUniversity of Lyon, University Lyon 1, Lyon, 69100, France.
Emmanuel MassyUniversity of Lyon, University Lyon 1, Lyon, 69100, France.
Nicolas FournierInternal medicine, National Reference Center for AutoInflammatory Diseases (CEREMAIA), University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, 69004, France.
Pascal SèveInternal medicine, National Reference Center for AutoInflammatory Diseases (CEREMAIA), University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, 69004, France.
Cyrille ConfavreuxUniversity of Lyon, University Lyon 1, Lyon, 69100, France.
Yvan Jamilloux *Internal medicine, National Reference Center for AutoInflammatory Diseases (CEREMAIA), University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, 69004, France.
Fabienne Coury *University of Lyon, University Lyon 1, Lyon, 69100, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Still’s disease (SD) and rheumatoid arthritis (RA), particularly seronegative RA, may overlap clinically and biologically, complicating diagnosis. We explored data-driven overlaps between SD, seronegative RA, and seropositive RA using unsupervised clustering. We retrospectively included 312 adults: 98 SD from the multicentric AURAL Still cohort and 214 RA (93 seropositive, 121 seronegative). Baseline clinical and laboratory data were analysed using factor analysis of mixed data followed by k-means clustering. SD patients were younger than RA patients and more frequently presented with fever and systemic features. Inflammatory markers (notably CRP and ferritin) were higher in SD than in both RA subsets. Three clusters were identified: Cluster 1 (n = 196) mainly comprised seropositive (45%) and seronegative RA (50%), with mild systemic inflammation and symmetrical polyarthritis; Cluster 2 (n = 73) was predominantly SD (92%), with systemic features, high inflammation and polyarthritis, and more frequent spontaneous remission without treatment; Cluster 3 (n = 43) mixed SD (49%) and seronegative RA (42%), characterised by moderate inflammation and asymmetrical oligoarthritis with low autoantibody rates. Most seronegative RA clustered with classical RA, but ~ 20% overlapped with SD-like phenotypes, suggesting a hyper-inflammatory subset which could be conceptualized as Systemic Inflammatory RA (SIRA). This proposal is hypothesis-generating and warrants prospective validation.

Indexed as

Arthritis, RheumatoidInflammationAdultAgedAutoantibodiesBiomarkersCluster AnalysisClustering AlgorithmsFemaleHumansMaleMiddle AgedRetrospective StudiesAutoantibodiesBiomarkers

Identifiers

PMID41735429
PMCPMC13031936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.